Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 3.61% is 38% below its 5-year average of 5.85%, near the low end of its 5-year range (3.52%–7.33%).
As of the fiscal period ended Tuesday, June 30, 2026. 37.44% below its 12-month average of 5.77%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.61%.
DEBT TO ASSETS RATIO
3.61%
DEBT TO ASSETS RATIO AVG TTM
5.77%
DEBT TO ASSETS RATIO AVG 3Y
6.58%
DEBT TO ASSETS RATIO AVG 5Y
5.85%
DEBT TO ASSETS RATIO AVG 10Y
6.10%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-37.44%
CURRENT VS 3Y AVG
-45.10%
CURRENT VS 5Y AVG
-38.28%
CURRENT VS 10Y AVG
-40.80%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
+3511.15%
vs the sector median at left
Market Cap
$3.44B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49B
Debt to Assets Ratio
0.67%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.34B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.10B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.09B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.08B
Debt to Assets Ratio
0.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareDx, Inc (CDNA) | $3.45B | 3.61% | 5.77% | 6.58% | 5.85% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 0.04% | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.49B | 0.67% | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.53B | 0.91% | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.54B | 0.02% | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.34B | 0.04% | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.10B | 0.02% | N/A | N/A | N/A |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | 0.02% | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.08B | 0.23% | N/A | N/A | N/A |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.07B | 0.00% | N/A | N/A | N/A |
Debt/Assets
3.6%
Debt/Equity
0.05
Current Ratio
4.58
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 3.61% |
| 2026-03-31 | 5.96% |
| 2025-12-31 | 6.34% |
| 2025-09-30 | 6.39% |
| 2025-06-30 | 6.56% |
| 2025-03-31 | 6.18% |
| 2024-12-31 | 5.78% |
| 2024-09-30 | 6.28% |
| 2024-06-30 | 6.74% |
| 2024-03-31 | 7.28% |
| 2023-12-31 | 7.33% |
| 2023-09-30 | 7.03% |
| 2023-06-30 | 7.07% |
| 2023-03-31 | 7.15% |
| 2022-12-31 | 7.18% |
| 2022-09-30 | 7.33% |
| 2022-06-30 | 3.52% |
| 2022-03-31 | 3.74% |
| 2021-12-31 | 3.77% |
| 2021-09-30 | 3.85% |
| 2021-06-30 | 3.79% |
| 2021-03-31 | 3.99% |
| 2020-12-31 | 4.91% |
| 2020-09-30 | 5.21% |
| 2020-06-30 | 5.44% |
| 2020-03-31 | 12.17% |
| 2019-12-31 | 3.55% |
| 2019-09-30 | 1.40% |
| 2019-06-30 | 1.42% |
| 2019-03-31 | 1.60% |
| 2018-12-31 | 0.13% |
| 2018-09-30 | 14.82% |
| 2018-06-30 | 16.87% |
| 2018-03-31 | 13.00% |
| 2017-12-31 | 40.76% |
| 2017-09-30 | 48.21% |
| 2017-06-30 | 43.64% |
| 2017-03-31 | 40.37% |
| 2016-12-31 | 31.21% |
| 2016-09-30 | 25.86% |
| 2016-06-30 | 28.85% |
| 2016-03-31 | 32.46% |
| 2015-12-31 | 28.31% |
| 2015-09-30 | 26.62% |
| 2015-06-30 | 25.70% |
| 2015-03-31 | 24.86% |
| 2014-12-31 | 18.67% |
| 2014-09-30 | 20.25% |
| 2014-06-30 | 55.22% |
| 2014-03-31 | 136.22% |
| 2013-12-31 | 156.16% |
